TR199701151T1 - Virüsler ve kanserlerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari ve N-klorofeniltiokarbamatlari içeren bir farmasötik bilesim. - Google Patents

Virüsler ve kanserlerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari ve N-klorofeniltiokarbamatlari içeren bir farmasötik bilesim.

Info

Publication number
TR199701151T1
TR199701151T1 TR97/01151T TR9701151T TR199701151T1 TR 199701151 T1 TR199701151 T1 TR 199701151T1 TR 97/01151 T TR97/01151 T TR 97/01151T TR 9701151 T TR9701151 T TR 9701151T TR 199701151 T1 TR199701151 T1 TR 199701151T1
Authority
TR
Turkey
Prior art keywords
chlorophenylthiocarbamates
cancers
pharmaceutical composition
composition containing
viruses
Prior art date
Application number
TR97/01151T
Other languages
English (en)
Inventor
Berger Camden James
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/420,913 external-priority patent/US5629341A/en
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199701151T1 publication Critical patent/TR199701151T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Bu bulus memelilerde, özellikle insan ve sicak-kanli hayvanlarda kanserler ve tümörlerin büyümesini engelleyen bir farmasötik bilesimdir. Bilesim ayni zamanda virüslere karsi da etkilidir. Bilesim, sistemik herbisidler olan N-klorofenilkarbamatlari ve N-klorofeniltiokarbamatlari ihtiva etmektedir. Bilesim ayni zamanda, bir kemoterapik madde ve istege göre bir potansiyatör ile yanyana N-klorofenilkarbamatlari ve N-klorofeniltiokarbamatlari da ihtiva eder. Hayvanlarda ya da insanlarda viral enfeksiyonlarin iyilestirilmesi için N-klorofenilkarbamatlari ve N-klorofeniltiokarbamatlarin ve bir potansiyatörün etkili ve emniyetli bir miktarini içeren bir bilesim de anlatilmistir.
TR97/01151T 1995-04-12 1996-04-11 Virüsler ve kanserlerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari ve N-klorofeniltiokarbamatlari içeren bir farmasötik bilesim. TR199701151T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/420,913 US5629341A (en) 1995-04-12 1995-04-12 Pharmaceutical composition for inhibiting the growth of viruses and cancers
US188895P 1995-08-04 1995-08-04

Publications (1)

Publication Number Publication Date
TR199701151T1 true TR199701151T1 (tr) 1998-03-21

Family

ID=26669618

Family Applications (2)

Application Number Title Priority Date Filing Date
TR1998/01216T TR199801216T2 (tr) 1995-04-12 1996-04-11 Virüslerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari ve N-klorofeniltiokarbamatlari içeren bir farmasötik bilesim.
TR97/01151T TR199701151T1 (tr) 1995-04-12 1996-04-11 Virüsler ve kanserlerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari ve N-klorofeniltiokarbamatlari içeren bir farmasötik bilesim.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR1998/01216T TR199801216T2 (tr) 1995-04-12 1996-04-11 Virüslerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari ve N-klorofeniltiokarbamatlari içeren bir farmasötik bilesim.

Country Status (21)

Country Link
US (3) US5932604A (tr)
EP (1) EP0820281B1 (tr)
JP (1) JPH11503460A (tr)
KR (1) KR19980703829A (tr)
CN (1) CN1181701A (tr)
AT (1) ATE367808T1 (tr)
AU (1) AU714056B2 (tr)
BR (1) BR9604973A (tr)
CA (1) CA2217953C (tr)
CZ (1) CZ323597A3 (tr)
DE (1) DE69637178D1 (tr)
HU (1) HUP9900901A3 (tr)
IL (1) IL117874A0 (tr)
NO (1) NO974696L (tr)
NZ (1) NZ305785A (tr)
PL (1) PL322732A1 (tr)
RU (1) RU2170577C2 (tr)
SK (1) SK138397A3 (tr)
TR (2) TR199801216T2 (tr)
TW (1) TW422685B (tr)
WO (1) WO1996032104A1 (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ323597A3 (cs) 1995-04-12 1998-03-18 The Procter & Gamble Company Farmaceutický prostředek obsahující N-chlorfenylkarbamáty a N-chlorfenylthiocarbamaty pro inhibici růstu virů a karcinom
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6225307B1 (en) * 1999-03-31 2001-05-01 The Procter & Gamble Company Viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734911A (en) * 1956-02-14 Reaction of chloroaniline and isopropyl
US2695225A (en) * 1954-05-21 1954-11-23 Columbia Southern Chem Corp Herbicidal compositions
US2806051A (en) * 1955-11-01 1957-09-10 Goodrich Co B F Method for preparing urethanes by reacting urea, amines and an alcohol
US3853530A (en) * 1971-03-10 1974-12-10 Monsanto Co Regulating plants with n-phosphonomethylglycine and derivatives thereof
US3799758A (en) * 1971-08-09 1974-03-26 Monsanto Co N-phosphonomethyl-glycine phytotoxicant compositions
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
EP0061872B1 (en) * 1981-03-30 1985-08-07 Takeda Chemical Industries, Ltd. Ethyleneglycol derivatives, their production and use
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
US4866059A (en) * 1988-04-04 1989-09-12 Warner-Lambert Company '(2S)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-carbamic acid, ethyl ester
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5254715A (en) * 1990-11-07 1993-10-19 Warner-Lambert Company Aminosulfonyl carbamates
US5656615A (en) 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
US5629341A (en) * 1995-04-12 1997-05-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
CZ323597A3 (cs) * 1995-04-12 1998-03-18 The Procter & Gamble Company Farmaceutický prostředek obsahující N-chlorfenylkarbamáty a N-chlorfenylthiocarbamaty pro inhibici růstu virů a karcinom

Also Published As

Publication number Publication date
CN1181701A (zh) 1998-05-13
SK138397A3 (en) 1998-05-06
HUP9900901A2 (hu) 1999-08-30
AU5389896A (en) 1996-10-30
NZ305785A (en) 2001-10-26
HUP9900901A3 (en) 1999-11-29
IL117874A0 (en) 1996-08-04
EP0820281A1 (en) 1998-01-28
US5932609A (en) 1999-08-03
ATE367808T1 (de) 2007-08-15
EP0820281B1 (en) 2007-07-25
CA2217953C (en) 2001-12-04
AU714056B2 (en) 1999-12-16
BR9604973A (pt) 1998-06-09
WO1996032104A1 (en) 1996-10-17
NO974696D0 (no) 1997-10-10
US6251870B1 (en) 2001-06-26
TR199801216T2 (tr) 1998-09-21
US5932604A (en) 1999-08-03
KR19980703829A (ko) 1998-12-05
RU2170577C2 (ru) 2001-07-20
JPH11503460A (ja) 1999-03-26
NO974696L (no) 1997-12-12
DE69637178D1 (de) 2007-09-06
PL322732A1 (en) 1998-02-16
TW422685B (en) 2001-02-21
CA2217953A1 (en) 1996-10-17
CZ323597A3 (cs) 1998-03-18

Similar Documents

Publication Publication Date Title
TR199701151T1 (tr) Virüsler ve kanserlerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari ve N-klorofeniltiokarbamatlari içeren bir farmasötik bilesim.
TR199701148T1 (tr) Virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-fosfonoglisin türevlerini içeren bir farmasötik bilesim.
DE69311556T2 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
EP0696326A4 (en) METHOD OF TREATING AND DETECTING CANCER USING VIRUSES
PT1002213E (pt) Sistema para proteger objectos contra cargas moldadas
BR0014320A (pt) Composições de substâncias terapêuticas solúveis em tocol
TR200101333T2 (tr) Bir ensülin sensitizörü ve başka bir anti-diyabetik maddenin değiştirilmiş salımı için farmasötik terkip.
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
TR199800848A2 (tr) Yükseltilmis in vivo uygunluga sahip bilesimler.
TR199701147T1 (tr) Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim.
TR199903332T2 (tr) Eletriptan hemisülfat ve kafein içeren farmasötikal bilesikler.
AR002987A1 (es) Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento
AU1366201A (en) Article irradiation system in which article transporting conveyor is closely encompassed by shielding material
TR199800270T1 (tr) Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi.
TR199800244T2 (tr) Griseofulvinin, kanserlerin ilerlemesini önlemede kullanimi.
KR880700321A (ko) 이온 빔 및 전자 빔 석판 인쇄용 폴리실록산 내식막
ATE236651T1 (de) Materialen und verfahren im zusammenhang mit der inhibierung der wechselwirkung der p53 und mdm2
EP0806203A3 (en) Anti-viral compositions
TR200100974T2 (tr) Virütik kaynaklı sistematik şok ve solunum zorluğunun,lenfotoksin beta yolunu bloke etmek suretiyle geri çevrilmesi
SE9803482D0 (sv) Ion exchange tumor targeting (IETT)
TR199801326A2 (tr) Iyilestirilmis, pestisit özellikli kaplama matrisler.
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
EP0457127A3 (en) Spermicidal coating
IT1183518B (it) Cassone ermetico in particolare per la protezione di oggetti, strumenti di misura e/o simili nei confronti di gas, polvere o mezzi deflagranti